$61.5M in CY2024 Part D spend100K claims · 34K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Ivabradine used for?
Ivabradine is a Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker medication tracked in Medicare Part D.
Is there a generic for Ivabradine?
Yes. 12 ANDAs filed at FDA, 6 generic manufacturers currently shipping.
How much does my plan pay for Ivabradine?
Across 329 Part D plans, Ivabradine averages $2.04/unit (NADAC). Lowest available: $0.844/unit. Highest in distribution: $9.99/unit.
Is Ivabradine on the FDA shortage list?
Ivabradine has been discontinued by its manufacturer(s).
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (16 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.